About Zhengbin (Bing) Yao
Zhengbin (Bing) Yao is a director at Alumis.
Zhengbin (Bing) Yao reports to the SEC as a director or officer of 5 public companies, including ArriVent BioPharma (AVBP), NexImmune (NEXI) and Viela Bio (VIE).
Zhengbin (Bing) Yao first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Zhengbin (Bing) Yao in the role, so the role may have started earlier or lasted longer.
AI
ArriVent BioPharma, Inc.
President and CEO, director
2024 – 2026 · Public company (AVBP)
NI
NexImmune, Inc.
Director
2021 – 2023 · Public company (NEXI)
VI
Viela Bio, Inc.
Chief Executive Officer and director
2019 – 2021 · Public company (VIE)
TI
Tanox Inc.
Vice President of Research
2006 · Public company (TNOX)
Key Colleagues at Startups
The people Zhengbin (Bing) Yao works with at each company, as listed on that company's latest Form D.
Alumis Inc. · Form D, Jul 24, 2024
SA
Srinivas Akkaraju
Director
JS
John Schroer
Executive officer
JT
James Tananbaum
Director
DR
Derrick Richardson
Executive officer
PM
Patrick Machado
Director
SS
Sapna Srivastava
Director
MB
Martin Babler
CEO and director
MB
Mark Bradley
Executive officer
SK
Sara Klein
Executive officer
DG
David Goldstein
Executive officer
JD
Jorn Drappa
Executive officer
AC
Alan Colowick
Director
RH
Roy Hardiman
Executive officer